Sa darating na March 30, 2022 (Miyerkules) ay iniimbitahan namin kayong dumalo sa ika-15 Policy Dialogue on Universal Healthcare and Access to Medicines o mas kilala sa tawag na Patient Forum.
The workshop aims to build on existing international and global collaboration on price transparency like information sharing platform initiatives of the WHO, the Price Information Exchange for Medicines (PIEMEDs) web-based platform. While some AMS such as the Philippines, Malaysia, Indonesia, Singapore, Viet Nam, Lao PDR and Thailand already provide price information in either of these continue reading : ASEAN Price Sharing Workshop
Bayview Park Hotel - Manila
1118 Roxas Boulevard, corner United Nations Avenue, Ermita, Manila, Manila, Metro Manila
Pursuant to the Government’s thrust towards Universal Health Care (UHC) and in light of the major changes in the pharmaceutical landscape, the Department of Health, through the Pharmaceutical Division (PD), is currently crafting the new medium-term Philippine Medicines Policy (PMP) to be implemented from the years 2022 to 2030. The policy document outlines an 8-year continue reading : Public Consultation for the Philippine Medicines Policy 2022-2030
The Department of Health - Pharmaceutical Division through the Medical Device Unit is currently in the process of creating the Philippine Essential Medical Device List (PEMDL), set price reference index for DOH health facilities, and provide guidelines on the enforcement, implementation, and monitoring of the system across DOH End-User units as mandated in the AO continue reading : Development of Guidelines in the Creation of Philippine Essential Medical Device List
The Department of Health – Pharmaceutical Division (PD) has been monitoring the management of essential medicines being downloaded to various health facilities through the National Drug Policy Compliance Officers (NDPCOs) and Public Health Pharmacists (PHPs). Their functions include mentoring the health professionals on good supply chain management practices, and ensuring that medicines are in good continue reading : Pharmaceutical Division Program Implementation Review with DOH Centers for Health Development
Pursuant to the Government’s thrust towards Universal Health Care (UHC) and in light of the major changes in the pharmaceutical landscape, the Department of Health, through the Pharmaceutical Division (PD), is currently crafting the new medium-term Philippine Medicines Policy (PMP) to be implemented from the years 2022 to 2030.
Pursuant to the Government’s thrust towards Universal Health Care (UHC) and in light of the major changes in the pharmaceutical landscape, the Department of Health, through the Pharmaceutical Division (PD), is currently crafting the new medium-term Philippine Medicines Policy (PMP) to be implemented from the years 2022 to 2030.
Pursuant to Republic Act (RA) No. 9502, otherwise known as the “Universally Accessible Cheaper and Quality Medicines Act of 2008” and its Implementing Rules and Regulations (IRR), the Advisory Council was created through the Department Personnel Order (DPO) No. 2009-5171 and DPO No. 2013-5044, to make recommendations to the Secretary of Health in appropriate measures to promote and ensure access by all Filipinos to affordable and quality essential medicines.
Monthly meeting between Medical Device Unit and Expert Advisory Committee for the Development of Guidelines for the Medical Devices and Supplies Price Reference Index (MDSPRI) and Philippine Essential Medical Device List (PEMDL) pursuant to Administrative Order No 2021-0038 entitled Framework for the Philippine Essential Medical Device List and Price Reference Index
The DOH Program to Combat Antimicrobial Resistance together with the designated DOH-retained hospitals as the AMS training hub continues to cascade the Antimicrobial Stewardship (AMS) Training Program to Level I hospitals scheduled this year.